Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sapropterin for Portal Hypertension in Liver Cirrhosis
NCT01456286Phase 3Completed
- Sponsor
- Fundació Clínic per a la Recerca Biomèdica
- Start
- Oct 2011
- Primary completion
- Oct 2013
- Modality
- Allosteric Modulators, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of sapropterin in Portal Hypertension (PH), sponsored by Fundació Clínic per a la Recerca Biomèdica. Started Oct 2011; status: completed.
02
Drugs
sapropterin
03
Conditions
Portal Hypertension (PH)
Beyond the preview
Go deeper on NCT01456286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01456286.